351 related articles for article (PubMed ID: 29568873)
1. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.
Yu YW; Li MX; Zhang ZY; Yu H
Int J Mol Med; 2018 Jun; 41(6):3577-3585. PubMed ID: 29568873
[TBL] [Abstract][Full Text] [Related]
2. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice.
Ding XM; Pan L; Wang Y; Xu QZ
Int J Mol Med; 2016 Mar; 37(3):703-15. PubMed ID: 26782291
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the CX3CL1/CX3CR1 Axis and Inflammatory Signaling Pathways in Tissue Injury.
Zhuang Q; Ou J; Zhang S; Ming Y
Curr Protein Pept Sci; 2019; 20(8):844-854. PubMed ID: 30843484
[TBL] [Abstract][Full Text] [Related]
4. CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.
Hou SM; Hou CH; Liu JF
Arthritis Res Ther; 2017 Dec; 19(1):282. PubMed ID: 29268768
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin Protects H9c2 Cells Against Injury Induced by Lipopolysaccharide via Suppression of CX3CL1/CX3CR1 Axis and NF-κB Activity.
Faridvand Y; Nemati M; Zamani-Gharehchamani E; Nejabati HR; Zamani ARN; Nozari S; Safaie N; Nouri M; Jodati A
Curr Mol Pharmacol; 2022; 15(6):862-869. PubMed ID: 34629047
[TBL] [Abstract][Full Text] [Related]
7. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
8. Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells.
Galán-Ganga M; García-Yagüe ÁJ; Lastres-Becker I
Cell Mol Neurobiol; 2019 Apr; 39(3):331-340. PubMed ID: 30830503
[TBL] [Abstract][Full Text] [Related]
9. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
10. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
[TBL] [Abstract][Full Text] [Related]
11. The CX3CL1/CX3CR1 axis is upregulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.
Li C; Zhong X; Xia W; He J; Gan H; Zhao H; Xia Y
Microvasc Res; 2020 Nov; 132():104037. PubMed ID: 32615135
[TBL] [Abstract][Full Text] [Related]
12. Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice.
Mizoguchi M; Ishida Y; Nosaka M; Kimura A; Kuninaka Y; Yahata T; Nanjo S; Toujima S; Minami S; Ino K; Mukaida N; Kondo T
PLoS One; 2018; 13(11):e0207085. PubMed ID: 30399192
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis.
Liu C; Hong K; Chen H; Niu Y; Duan W; Liu Y; Ji Y; Deng B; Li Y; Li Z; Wen D; Li C
Biol Chem; 2019 Apr; 400(5):651-661. PubMed ID: 30352020
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
Cormican S; Griffin MD
Front Immunol; 2021; 12():664202. PubMed ID: 34163473
[TBL] [Abstract][Full Text] [Related]
15. CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
Zhuang Q; Cheng K; Ming Y
Curr Gene Ther; 2017; 17(6):442-452. PubMed ID: 29446734
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism.
Liu Y; Zhang T; Meng D; Sun L; Yang G; He Y; Zhang C
Behav Brain Res; 2020 Mar; 381():112371. PubMed ID: 31765724
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments.
Szukiewicz D; Szewczyk G; Pyzlak M; Stangret A; Bachanek M; Trojanowski S; Alkhalayla H; Wejman J
Inflammation; 2018 Dec; 41(6):2246-2264. PubMed ID: 30097812
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
19. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling.
Frias-Anaya E; Gallego-Gutierrez H; Gongol B; Weinsheimer S; Lai CC; Orecchioni M; Sriram A; Bui CM; Nelsen B; Hale P; Pham A; Shenkar R; DeBiasse D; Lightle R; Girard R; Li Y; Srinath A; Daneman R; Nudleman E; Sun H; Guma M; Dubrac A; Mesarwi OA; Ley K; Kim H; Awad IA; Ginsberg MH; Lopez-Ramirez MA
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1246-1264. PubMed ID: 38660801
[TBL] [Abstract][Full Text] [Related]
20. CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.
Nagashimada M; Sawamoto K; Ni Y; Kitade H; Nagata N; Xu L; Kobori M; Mukaida N; Yamashita T; Kaneko S; Ota T
Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33765141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
